Videos de Experimentos Relacionados
Resumen
Infarto sin obstrucción arterial es común en el cerebro y el intestino, pero raro en el corazón y las piernas. Las obstrucciones arteriales sin infarto son frecuentes en las cuatro áreas, destacando factores más allá de la aterosclerosis.
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Calf management and welfare in the Canadian and US dairy industries: Where do we go from here?
Journal of dairy science·2023
Same author
Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy.
ESMO open·2021
Same author
Demographics, natural history and treatment outcomes of non-molar gestational choriocarcinoma: a UK population study.
BJOG : an international journal of obstetrics and gynaecology·2020
Same author
Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study.
BJOG : an international journal of obstetrics and gynaecology·2019
Same author
The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia.
European journal of cancer (Oxford, England : 1990)·2019
Same author
Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
European journal of obstetrics, gynecology, and reproductive biology·2019
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026